BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30489634)

  • 1. Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study.
    Barzilai O; Versteeg AL; Sahgal A; Rhines LD; Bilsky MH; Sciubba DM; Schuster JM; Weber MH; Pal Varga P; Boriani S; Bettegowda C; Fehlings MG; Yamada Y; Clarke MJ; Arnold PM; Gokaslan ZL; Fisher CG; Laufer I; The Ao Spine Knowledge Forum Tumor
    Cancer; 2019 Mar; 125(5):770-778. PubMed ID: 30489634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and Sex Differences in Health-related Quality of Life, Clinical Outcomes and Survival after Treatment of Metastatic Spine Disease.
    Goodwin CR; Price M; Goodwin AN; Dalton T; Versteeg AL; Sahgal A; Rhines LD; Schuster JM; Weber MH; Lazary A; Boriani S; Bettegowda C; Fehlings MG; Arnold PM; Dea N; Charest-Morin R; Shin J; Laufer I; Chou D; Gokaslan ZL; Clarke MJ; Fisher CG; Sciubba DM;
    Spine (Phila Pa 1976); 2023 Dec; ():. PubMed ID: 38149519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of radiotherapy in oligometastatic breast cancer: Review of the literature.
    Beduk Esen CS; Gultekin M; Yildiz F
    World J Clin Oncol; 2022 Jan; 13(1):39-48. PubMed ID: 35116231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life of Oligometastatic and Polymetastatic Head and Neck Squamous Cell Carcinoma Patients.
    Berzenji D; Dorr MC; Sewnaik A; Mast H; Offerman MPJ; Baatenburg de Jong RJ; Hardillo JA
    Laryngoscope; 2024 Feb; ():. PubMed ID: 38326981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: A review.
    Vanden Berg RNW; Zilli T; Achard V; Dorff T; Abern M
    Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):702-711. PubMed ID: 37422523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation and Validation of the Spine Oncology Study Group Outcomes Questionnaire in Italian Language.
    Brodano GB; Pesce E; Griffoni C; Carretta E; Noli LE; Errani C; Trentin F; Leopardi MP; Mavilla L; Gasbarrini A
    Global Spine J; 2023 Oct; 13(8):2367-2378. PubMed ID: 35344384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Multi-Site Radiation Therapy for Systemic Disease Control.
    Patel RR; Verma V; Barsoumian HB; Ning MS; Chun SG; Tang C; Chang JY; Lee PP; Gandhi S; Balter P; Dunn JD; Chen D; Puebla-Osorio N; Cortez MA; Welsh JW
    Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):352-364. PubMed ID: 32798606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introducing the New Patient Expectations in Spine Oncology Questionnaire.
    Versteeg AL; Gal R; Charest-Morin R; Reichl L; Tsang A; Aludino A; Sahgal A; Verlaan JJ; Fisher CG; Verkooijen HM
    Neurosurgery; 2023 Dec; 93(6):1331-1338. PubMed ID: 37409831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of radiation therapy for de novo metastatic bladder and renal cancers.
    Sargos P; Le Guevelou J; Khalifa J; Albiges L; Azria D; de Crevoisier R; Supiot S; Créhange G; Roubaud G; Chapet O; Pasquier D; Blanchard P; Latorzeff I
    Cancer Radiother; 2024 Feb; 28(1):56-65. PubMed ID: 37286452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligometastatic Disease in Upper Gastrointestinal Cancer - How to Proceed?
    Chiapponi C; Berlth F; Plum PS; Betzler C; Stippel DL; Popp F; Bruns CJ
    Visc Med; 2017 Mar; 33(1):31-34. PubMed ID: 28612014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligometastatic disease: a need for consensus to cure the incurable in a multidisciplinary approach.
    Martinez-Recio S; Barba A; Farré N; Majem M
    Chin Clin Oncol; 2024 Apr; 13(2):28. PubMed ID: 38199796
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiotherapy of Oligometastatic Cancers.
    Alongi F; Gaito S
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retooling treatment in oligometastatic oesophageal cancer.
    Cammarota A; Hawkins MA; Smyth EC
    Lancet Gastroenterol Hepatol; 2024 Jan; 9(1):5-7. PubMed ID: 37980923
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient satisfaction with treatment outcomes after surgery and/or radiotherapy for spinal metastases.
    Versteeg AL; Sahgal A; Kawahara N; Rhines LD; Sciubba DM; Weber MH; Lazary Á; Fehlings MG; Schuster JM; Clarke MJ; Arnold PM; Boriani S; Bettegowda C; Gokaslan ZL; Fisher CG;
    Cancer; 2019 Dec; 125(23):4269-4277. PubMed ID: 31490548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of neurologic deficits with surgical outcomes and health-related quality of life after treatment for metastatic epidural spinal cord compression.
    Barzilai O; Versteeg AL; Goodwin CR; Sahgal A; Rhines LD; Sciubba DM; Schuster JM; Weber MH; Lazary A; Fehlings MG; Clarke MJ; Arnold PM; Boriani S; Bettegowda C; Gokaslan ZL; Fisher CG; Laufer I;
    Cancer; 2019 Dec; 125(23):4224-4231. PubMed ID: 31410854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation surgery for metastatic epidural spinal cord compression: A qualitative review.
    Di Perna G; Cofano F; Mantovani C; Badellino S; Marengo N; Ajello M; Comite LM; Palmieri G; Tartara F; Zenga F; Ricardi U; Garbossa D
    J Bone Oncol; 2020 Dec; 25():100320. PubMed ID: 33088700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential Concepts for the Management of Metastatic Spine Disease: What the Surgeon Should Know and Practice.
    Barzilai O; Boriani S; Fisher CG; Sahgal A; Verlaan JJ; Gokaslan ZL; Lazary A; Bettegowda C; Rhines LD; Laufer I
    Global Spine J; 2019 May; 9(1 Suppl):98S-107S. PubMed ID: 31157152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome analysis of surgery for symptomatic spinal metastases in long-term cancer survivors.
    Barzilai O; McLaughlin L; Lis E; Yamada Y; Bilsky MH; Laufer I
    J Neurosurg Spine; 2019 Apr; 31(2):285-290. PubMed ID: 31026814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.
    Guckenberger M; Lievens Y; Bouma AB; Collette L; Dekker A; deSouza NM; Dingemans AC; Fournier B; Hurkmans C; Lecouvet FE; Meattini I; Méndez Romero A; Ricardi U; Russell NS; Schanne DH; Scorsetti M; Tombal B; Verellen D; Verfaillie C; Ost P
    Lancet Oncol; 2020 Jan; 21(1):e18-e28. PubMed ID: 31908301
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.